New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
07:59 EDTARII, CP, TRN, CNI, GBX, BRK.ARegulators knew about crude-by-rail risks before crashes, NBC says
Regulators knew about issues like overloading and mislabeling that could increase the risk of shipping crude oil by rail since as early as Fall 2011, documents obtained by NBC News show. Train operators that offer crude-by-rail services include Canadian National (CNI), Canadian Pacific (CP) and BNSF, part of Berkshire Hathaway (BRK.A). Manufacturers of of rail tankcars include Trinity Industries (TRN), American Railcar (ARII), and Greenbrier (GBX). Reference Link
News For A;TRN;ARII;GBX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 12, 2015
08:06 EDTALabCorp to offer new PD-L1 test for Bristol-Myers' Opdivo
Subscribe for More Information
05:17 EDTADasko announces FDA approval of Opdivo for patients with non-squamous NSCLC
Subscribe for More Information
October 9, 2015
18:31 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for OPDIVO
Subscribe for More Information
15:23 EDTADako announces FDA approval of new lung test for cancer patients
Subscribe for More Information
October 7, 2015
06:12 EDTGBXGreenbrier announces order from Saudi Railway Company for 1,200 railcars
Greenbrier announced that it received an order in Q4 from the government-owned Saudi Railway Company, or SAR, for approximately 1,200 railroad tank cars. Three types of tank cars will support industrial mining operations - led by the national mining company, Ma'aden - at Wa'ad al Shamal Industrial City in the Sirhan-Turaif region of northern Saudi Arabia. The tank cars will facilitate rail transportation of molten sulfur and phosphoric acid, products that are used in a range of industrial activities. Greenbrier will build the tank cars for SAR under U.S. supervision and management at its wholly-owned Wagony Swidnica subsidiary in Swidnica, Poland. Track dimensions in Saudi Arabia are identical to those in the United States, and the tank cars will be built to U.S. standards on production lines certified by the Association of American Railroads. Delivery of the first tank cars to SAR will begin in the second half of calendar year 2016, and will be completed in 2017 and 2018, depending on car type.
06:11 EDTGBXGreenbrier announces orders for 2,900 railcars valued at $470M
Subscribe for More Information
06:09 EDTGBXGreenbrier expects to exceed FY15 EPS view of $5.70-$5.85, consensus $5.79
Greenbrier announced that it expects to exceed previously provided diluted EPS guidance of $5.70-$5.85, excluding non-recurring costs in Q3 of 16c per share, for FY15. These higher expectations are principally driven by increased margins in the company's manufacturing segment, which includes lease syndications and a lower than anticipated tax rate related to geographic mix of earnings.
October 6, 2015
07:23 EDTAAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 5, 2015
05:29 EDTADako announces FDA approval of new companion diagnostic assay
Subscribe for More Information
October 2, 2015
15:57 EDTALabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
15:43 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
15:25 EDTAAgilent's Dako confirms FDA approval of NSCLC diagnostic
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced the FDA approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer, or NSCLC, is likely to respond to a new form of treatment. The approval of PD-L1 IHC 22C3 pharmDx strengthens Dako's portfolio of companion diagnostics and the company's leadership position in developing and commercializing companion diagnostic products. Dako developed PD-L1 IHC 22C3 pharmDx in partnership with Merck (MRK), maker of the anti-PD-1 therapy Keytruda. The FDA approved PD-L1 IHC 22C3 pharmDx for use in the United States. Dako hopes to gain regulatory approval for the new diagnostic in Canada, Europe and other jurisdictions next year.
October 1, 2015
09:36 EDTGBX, ARII, TRNRailcar sector downgraded to Negative from Mixed at OTR Global
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use